Pulmonary dispersion formulations: The impact of dispersed powder properties on pressurized metered dose inhaler stability

References

• Itoh H, Nishino M, Hatabu H. (2004). Architecture of the lung: morphology and function. J Thorac Imaging, 19:221–227.
   PubMed Web of Science ®Google Scholar
• Patton JS, Byron PR. (2007). Inhaling medicines: delivering drugs to the body through the lungs. Nat Rev Drug Discov, 6:67–74.
   PubMed Web of Science ®Google Scholar
• Garcia-Contreras L, Smyth HDC. (2005). Liquid-spray or dry powder systems for inhaled delivery of peptide and proteins? Am J Drug Deliv 3:29–45.
   Google Scholar
• O’Callaghan, C, Wright P. (2001). The Metered-Dose Inhaler. Drug Delivery to the Lung. In: Bisgaard H, O’Callaghan, C, Smalderone, G. ed. New York:Informa Healthcare.
   Google Scholar
• Smyth HD. (2003). The influence of formulation variables on the performance of alternative propellant-driven metered dose inhalers. Adv Drug Deliv Rev, 55:807–828.
   PubMed Web of Science ®Google Scholar
• Ball D, Blanchard J, Jacobson-Kram D, McClellan RO, McGovern T, Norwood DL et al. (2007). Development of safety qualification thresholds and their use in orally inhaled and nasal drug product evaluation. Toxicol Sci, 97:226–236.
   PubMed Web of Science ®Google Scholar
• Dohmeier DM, Norwood DL, Reckzuegel G, Stults CL, Nagao LM. (2009). Use of polymeric materials in orally inhaled and nasal drug products. Med Device Technol, 20: 32, 34, 36–32, 34, 38.
   PubMedGoogle Scholar
• Pritchard, JN. (2001). The influence of lung deposition on clinical response 1. J Aerosol Med - Deposition Clearance and Effects in the Lung 14: S19–S26.
   PubMedGoogle Scholar
• Carvalho TC, Peters JI, Williams RO 3rd. (2011). Influence of particle size on regional lung deposition–what evidence is there? Int J Pharm, 406:1–10.
   PubMed Web of Science ®Google Scholar
• Bisgaard, H, Anhoj, J, Wildhaber, JH. (2002). Spacer devices. Lung Biolo Health Dis 162: 389–420.
   Google Scholar
• Berry J, Heimbecher S, Hart JL, Sequeira J. (2003). Influence of the metering chamber volume and actuator design on the aerodynamic particle size of a metered dose inhaler. Drug Dev Ind Pharm, 29:865–876.
   PubMed Web of Science ®Google Scholar
• Wilson AF, Mukai DS, Ahdout JJ. (1991). Effect of canister temperature on performance of metered-dose inhalers. Am Rev Respir Dis, 143:1034–1037.
   PubMed Web of Science ®Google Scholar
• Hoye WL, Mogalian EM, Myrdal PB. (2005). Effects of extreme temperatures on drug delivery of albuterol sulfate hydrofluoroalkane inhalation aerosols. Am J Health Syst Pharm, 62:2271–2277.
   PubMed Web of Science ®Google Scholar
• Soine WH, Blondino FE, Byron PR. (1992). Chemical stability in pressurized inhlaers formulated as solutions. J Biopharmaceut Sci 3:41–47.
   Google Scholar
• Tzou TZ, Pachuta RR, Coy RB, Schultz RK. (1997). Drug form selection in albuterol-containing metered-dose inhaler formulations and its impact on chemical and physical stability. J Pharm Sci, 86:1352–1357.
   PubMed Web of Science ®Google Scholar
• Atkins PJ, Crowder TM. (2004). The design and development of inhalation drug delivery systems. In: Hickey AJ, Pharmaceutical inhalation aerosol technology. New York:Marcel Dekker, 279–310.
   Google Scholar
• U.N. (1989). Montreal Protocol on Substances that Deplete the Ozone Layer. New York: Liaison Office of the United Nations Environmental Program.
   Google Scholar
• Purewal TS. Greenleaf DJ. (1990). Medicinal aerosol formulations. E. P. 0372777.
   Google Scholar
• Byron PR, Miller NC, Blondino FE, Visisch JE, Ward GH. (1994). Some aspects of alternative propellant solvency. In: Byron PR, Dalby RN, Farr SJ. ed. Respiratory Drug Delivery IV. Buffalo Grove:Interpharm Press, 231–242.
   Google Scholar
• McDonald KJ, Martin GP. (2000). Transition to CFC-free metered dose inhalers–into the new millennium. Int J Pharm, 201:89–107.
   PubMed Web of Science ®Google Scholar
• Wu L, da Rocha SR. (2007). Biocompatible and biodegradable copolymer stabilizers for hydrofluoroalkane dispersions: a colloidal probe microscopy investigation. Langmuir, 23:12104–12110.
   PubMed Web of Science ®Google Scholar
• Wu L, Peguin RPS, Selvam P, Chokshi U, da Rocha, SRP. (2007). Molecular scale behavior in alternative propellant-based inhaler formulations. Lung Biol Health Dis 221:373–398.
   Google Scholar
• Blondino FE, Byron PR. (1998). Surfactant dissolution and water solubilization in chlorine-free liquified gas propellants. Drug Dev Ind Pharm, 24:935–945.
   PubMed Web of Science ®Google Scholar
• Williams, RO III, Hu, C, . (2000). Investigation of moisture scavengers in pressurized metered-dose inhalers. S.T.P. Pharma Sciences 10:243–250.
   Web of Science ®Google Scholar
• Williams RO 3rd, Hu C. (2000). Moisture uptake and its influence on pressurized metered-dose inhalers. Pharm Dev Technol, 5:153–162.
   PubMed Web of Science ®Google Scholar
• Vervaet C, Byron PR. (1999). Drug - surfactant - propellant interations in HFA - formulations. Int J Pharma, 186: 13–30.
   Google Scholar
• Gonda, I. (1985). Development of a systematic theory of suspension inhalation aerosols. I. A framework to study the effects of aggregation on the aerodynamic behaviour of drug particles. Int J Pharmaceut 27: 99–116.
   Web of Science ®Google Scholar
• Purewal, TS., Grant, DJW. (1998). Metered dose inhaler technology. Buffalo Grove:Interpharm Press.
   Google Scholar
• Yang W, Peters JI, Williams RO 3rd. (2008). Inhaled nanoparticles–a current review. Int J Pharm, 356:239–247.
   PubMed Web of Science ®Google Scholar
• Rabinow BE. (2004). Nanosuspensions in drug delivery. Nat Rev Drug Discov, 3:785–796.
   PubMed Web of Science ®Google Scholar
• Yang, B. (2008). Thermal conductivity equations based on Brownian motion in suspensions of nanoparticles (Nanofluids). J Heat Transfer 130.
   Web of Science ®Google Scholar
• Yang W, Peters JI, Williams RO 3rd. (2008). Inhaled nanoparticles–a current review. Int J Pharm, 356:239–247.
   PubMed Web of Science ®Google Scholar
• Matthews BA, Rhodes CT. (1970). The use of a comparative analysis of sedimentation and Brownian motion as a guide to suspension formulation. Pharm Acta Helv, 45:52–59.
   PubMedGoogle Scholar
• Williams, R, Shaw, DJ, Biggs, S. (2007). Introduction to Colloid and Surface Chemistry. London:Butterworth-Heinemann.
   Google Scholar
• Michael Y, Snowden MJ, Chowdhry BZ, Ashurst IC, Davies-Cutting CJ, Riley T. (2001). Characterisation of the aggregation behaviour in a salmeterol and fluticasone propionate inhalation aerosol system. Int J Pharm, 221:165–174.
   PubMed Web of Science ®Google Scholar
• Hickey AJ, Concessio NM. (1994). Flow properties of selected pharmaceutical powders from a vibrating spatula. Part Part Sys Characterization 11:457–462.
   Web of Science ®Google Scholar
• Lee RW, McShane J, Shaw JM, Wood RW, Shenoy DB. (2008). Particle size reduction. In: R., Liu, ed. Water-insoluble drug formulation. Boca Raton:CRC Press: 467–498.
   Google Scholar
• Nyambura BK, Kellaway IW, Taylor KM. (2009). Insulin nanoparticles: stability and aerosolization from pressurized metered dose inhalers. Int J Pharm, 375:114–122.
   PubMed Web of Science ®Google Scholar
• Bailey MM, Berkland CJ. (2009). Nanoparticle formulations in pulmonary drug delivery. Med Res Rev, 29:196–212.
   PubMed Web of Science ®Google Scholar
• Berry J, Kline LC, Sherwood JK, Chaudhry S, Obenauer-Kutner L, Hart JL et al. (2004). Influence of the size of micronized active pharmaceutical ingredient on the aerodynamic particle size and stability of a metered dose inhaler. Drug Dev Ind Pharm, 30:705–714.
   PubMed Web of Science ®Google Scholar
• Junghanns JAH, Mueller RH. (2008). Nanocrystal technology, drug delivery and clinical applications. Int J Nanomed 3: 295–309.
   PubMed Web of Science ®Google Scholar
• Nichols G, Byard S, Bloxham MJ, Botterill J, Dawson NJ, Dennis A et al. (2002). A review of the terms agglomerate and aggregate with a recommendation for nomenclature used in powder and particle characterization. J Pharm Sci, 91:2103–2109.
   PubMed Web of Science ®Google Scholar
• Merisko-Liversidge E, Liversidge GG, Cooper ER. (2003). Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci, 18:113–120.
   PubMed Web of Science ®Google Scholar
• Lei M, Juan W, Zuqing B, Jun Z. (1999). Kinetics of crystal growth of BDP and its solvates in trichlorofluoromethane and their influence on the performance of metered dose inhalers. J Chin Pharmaceut Sci 8:142–147.
   Google Scholar
• Phillips EM, Byron PR, Dalby RN. (1993). Axial ratio measurements for early detection of crystal growth in suspension-type metered dose inhalers. Pharm Res, 10:454–456.
   PubMed Web of Science ®Google Scholar
• Williams RO 3rd, Brown J, Liu J. (1999). Influence of micronization method on the performance of a suspension triamcinolone acetonide pressurized metered-dose inhaler formulation. Pharm Dev Technol, 4:167–179.
   PubMed Web of Science ®Google Scholar
• Lindfors L, Skantze P, Skantze U, Westergren J, Olsson U. (2007). Amorphous drug nanosuspensions. 3. Particle dissolution and crystal growth. Langmuir, 23:9866–9874.
   PubMed Web of Science ®Google Scholar
• Rogueda P. (2005). Novel hydrofluoroalkane suspension formulations for respiratory drug delivery. Expert Opin Drug Deliv, 2:625–638.
   PubMedGoogle Scholar
• Phillips EM. (1992). Crystal growth-formulation dependence and early detection. J Biopharmaceut Sci 3:11–18.
   Google Scholar
• Newell HE, Buckton G, Butler DA, Thielmann F, Williams DR. (2001). The use of inverse phase gas chromatography to measure the surface energy of crystalline, amorphous, and recently milled lactose. Pharm Res, 18:662–666.
   PubMed Web of Science ®Google Scholar
• Ranucci JA, Dixit S, Bray RN, Goldman D. (1990). Controlled flocculation in metered-dose aerosol suspensions. Pharmaceut Technol 14:68–74.
   Google Scholar
• Young PM, Adi H, Patel T, Law K, Rogueda P, Traini D. (2009). The influence of micronised particulates on the aerosolisation properties of pressurised metered dose inhalers. Aerosol Sci 40:324–337.
   Web of Science ®Google Scholar
• James J, Crean B, Davies M, Toon R, Jinks P, Roberts CJ. (2008). The surface characterisation and comparison of two potential sub-micron, sugar bulking excipients for use in low-dose, suspension formulations in metered dose inhalers. Int J Pharm, 361:209–221.
   PubMed Web of Science ®Google Scholar
• Tzou T-Z. (1998). Density, excess molar volume, and vapor pressure of propellant mixtures in metered-dose inhalers: deviation from ideal mixtures. Respiratory Drug Delivery VI: Biological, pharmaceutical, clinical and regulatory issues relating to optimized drug delivery by aerosol, the International Symposium, Hilton Head, S.C.
   Google Scholar
• Williams RO 3rd, Repka M, Liu J. (1998). Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler. Drug Dev Ind Pharm, 24:763–770.
   PubMed Web of Science ®Google Scholar
• Robins E, Williams G, Priolkar S. (2007). Development of a pMDI formulation containing salbutamol. Indian J Pharmaceut Sci 69: 724–726.
   Google Scholar
• Hirst PH, Pitcairn GR, Weers JG, Tarara TE, Clark AR, Dellamary LA et al. (2002). In vivo lung deposition of hollow porous particles from a pressurized metered dose inhaler. Pharm Res, 19:258–264.
   PubMed Web of Science ®Google Scholar
• Weers J. (2000). Dispersible powders for inhalation applications. Innovat Pharmaceut Technol 1:111–116.
   Google Scholar
• Edwards DA, Ben-Jebria A, Langer R. (1998). Recent advances in pulmonary drug delivery using large, porous inhaled particles. J Appl Physiol, 85:379–385.
   PubMed Web of Science ®Google Scholar
• Dellamary LA, Tarara TE, Smith DJ, Woelk CH, Adractas A, Costello ML et al. (2000). Hollow porous particles in metered dose inhalers. Pharm Res, 17:168–174.
   PubMed Web of Science ®Google Scholar
• Rosenholm JB, Peiponen KE, Gornov E. (2008). Materials cohesion and interaction forces. Adv Colloid Interface Sci, 141:48–65.
   PubMed Web of Science ®Google Scholar
• Tadmor R. (2001). The London-van der Waals interaction energy between objects of various geometries. J Physics: Condensed Matter 13:L195–L202.
   Web of Science ®Google Scholar
• Tang P, Greenwood J, Raper JA. (2002). A model to describe the settling behavior of fractal aggregates. J Colloid Interface Sci, 247:210–219.
   PubMed Web of Science ®Google Scholar
• Fargues C, Turchiuli C. (2003). Structural characterization of flocs in relation to their settling performances. Trans IChemE 81(Part A):1171–1178.
   Google Scholar
• Zhanpeng J, Yuntao G. (2006). Flocculation morphology: effect of particulate shape and coagulant species on flocculation. Water Sci Technol, 53:9–16.
   PubMed Web of Science ®Google Scholar
• Philipse AP. (1996). The random contact equation and its implications for (colloidal) rods in packings, suspensions, and anisotropic powders. Langmuir 12: 1127–1133.
   Web of Science ®Google Scholar
• Engstrom JD, Tam JM, Miller MA, Williams RO 3rd, Johnston KP. (2009). Templated open flocs of nanorods for enhanced pulmonary delivery with pressurized metered dose inhalers. Pharm Res, 26:101–117.
   PubMed Web of Science ®Google Scholar
• Tam JM, Engstrom JD, Ferrer D, Williams RO 3rd, Johnston KP. (2010). Templated open flocs of anisotropic particles for pulmonary delivery with pressurized metered dose inhalers. J Pharm Sci, 99:3150–3165.
   PubMed Web of Science ®Google Scholar
• Reist PC. (1993). Aerosol science and technology, New York, NY: McGraw-Hill.
   Google Scholar
• Edwards DA, Hanes J, Caponetti G, Hrkach J, Ben-Jebria A, Eskew ML et al. (1997). Large porous particles for pulmonary drug delivery. Science, 276:1868–1871.
   PubMed Web of Science ®Google Scholar
• Musante CJ, Schroeter JD, Rosati JA, Crowder TM, Hickey AJ, Martonen TB. (2002). Factors affecting the deposition of inhaled porous drug particles. J Pharm Sci, 91:1590–1600.
   PubMed Web of Science ®Google Scholar
• Cummings, RH. (1999). Pressurized metered dose inhalers: chlorofluorocarbon to hydrofluoroalkane transition - valve performance.J Allergy and Clin Immunol, 104:s230–s235.
   Google Scholar
• Sherwood JK, Alex S, Salama G, Obenauer-Kutner L, Huyck S, Berry J et al. (2007). Particle size coarsening induced by valve silicone in a metered dose inhaler. Drug Dev Ind Pharm, 33:155–162.
   PubMed Web of Science ®Google Scholar
• Parsons GE, Buckton G, Chatham SM. (1992). The use of surface energy and polarity determinations to predict physical stability of non-polar, non-aqueous suspensions. Int J Pharmaceut 83:163–170.
   Web of Science ®Google Scholar
• Buckton G, Choularton A, Beezer AE, Chatham SM. (1988). The effect of the comminution technique on the surface energy of a powder. Int J Pharmaceut 47: 121–128.
   Web of Science ®Google Scholar
• Traini D, Rogueda P, Young P, Price R. (2005). Surface energy and interparticle forces correlations in model pMDI formulations. Pharm Res, 22:816–825.
   PubMed Web of Science ®Google Scholar
• Traini D, Young PM, Rogueda P, Price R (2006). The use of AFM and surface energy measurements to investigate drug-canister material interactions in a model pressurized metered dose inhaler formulation. Aerosol Sci Technol 40:227–236.
   Web of Science ®Google Scholar
• Traini D, Young PM, Rogueda P, Price R. (2007). In vitro investigation of drug particulates interactions and aerosol performance of pressurised metered dose inhalers. Pharm Res, 24:125–135.
   PubMed Web of Science ®Google Scholar
• Ashayer R, Luckham PF, Manimaaran S, Rogueda P. (2004). Investigation of the molecular interactions in a pMDI formulation by atomic force microscopy. Eur J Pharm Sci, 21:533–543.
   PubMed Web of Science ®Google Scholar
• Young PM, Price R, Lewis D, Edge S, Traini D. (2003). Under pressure: predicting pressurized metered dose inhaler interactions using the atomic force microscope. J Colloid Interface Sci, 262:298–302.
   PubMed Web of Science ®Google Scholar
• Hooton JC, German CS, Allen S, Davies MC, Roberts CJ, Tendler SJ et al. (2003). Characterization of particle-interactions by atomic force microscopy: effect of contact area. Pharm Res, 20:508–514.
   PubMed Web of Science ®Google Scholar
• Peguin RP, da Rocha SR. (2008). Solvent-solute interactions in hydrofluoroalkane propellants. J Phys Chem B, 112:8084–8094.
   PubMed Web of Science ®Google Scholar
• Wu L, Al-Haydari M, da Rocha SR. (2008). Novel propellant-driven inhalation formulations: engineering polar drug particles with surface-trapped hydrofluoroalkane-philes. Eur J Pharm Sci, 33:146–158.
   PubMed Web of Science ®Google Scholar
• Wu L, Bharatwaj B, Panyam J, da Rocha SR. (2008). Core-shell particles for the dispersion of small polar drugs and biomolecules in hydrofluoroalkane propellants. Pharm Res, 25:289–301.
   PubMed Web of Science ®Google Scholar
• Li HY, Seville PC. (2010). Novel pMDI formulations for pulmonary delivery of proteins. Int J Pharm, 385:73–78.
   PubMed Web of Science ®Google Scholar
• Tarara TE, Hartman MS, Gill H, Kennedy AA, Weers JG. (2004). Characterization of suspension-based metered dose inhaler formulations composed of spray-dried budesonide microcrystals dispersed in HFA-134a. Pharm Res, 21:1607–1614.
   PubMed Web of Science ®Google Scholar